RASSF2 and cancer: In head and neck cancers, overexpression of miR-7 in CAFs leads to downregulation of RASSF2, which greatly reduces the secretion of protease-activated receptor 4 (PAR-4), a proapoptotic factor in cancer cells, thus leading to enhancement of cancer cell proliferation [114].